rs372174278

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5

The NM_032620.4(GTPBP3):ā€‹c.964G>Cā€‹(p.Ala322Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000916 in 1,605,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000092 ( 0 hom., cov: 33)
Exomes š‘“: 0.000092 ( 0 hom. )

Consequence

GTPBP3
NM_032620.4 missense

Scores

8
9
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:2

Conservation

PhyloP100: 8.55
Variant links:
Genes affected
GTPBP3 (HGNC:14880): (GTP binding protein 3, mitochondrial) This locus encodes a GTP-binding protein. The encoded protein is localized to the mitochondria and may play a role in mitochondrial tRNA modification. Polymorphisms at this locus may be associated with severity of aminoglycoside-induced deafness, a disease associated with a mutation in the 12S rRNA. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Sep 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a domain TrmE-type G (size 167) in uniprot entity GTPB3_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_032620.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.926
PP5
Variant 19-17339589-G-C is Pathogenic according to our data. Variant chr19-17339589-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 180617.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Likely_pathogenic=1}. Variant chr19-17339589-G-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GTPBP3NM_032620.4 linkc.964G>C p.Ala322Pro missense_variant 7/9 ENST00000324894.13 NP_116009.2 Q969Y2-1
GTPBP3NM_133644.4 linkc.1060G>C p.Ala354Pro missense_variant 6/8 NP_598399.2 Q969Y2-2B7Z563
GTPBP3NM_001195422.1 linkc.1030G>C p.Ala344Pro missense_variant 7/9 NP_001182351.1 Q969Y2-4B7Z563
GTPBP3NM_001128855.3 linkc.964G>C p.Ala322Pro missense_variant 7/9 NP_001122327.1 Q969Y2-3B7Z563

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GTPBP3ENST00000324894.13 linkc.964G>C p.Ala322Pro missense_variant 7/91 NM_032620.4 ENSP00000313818.7 Q969Y2-1

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152186
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000117
AC:
27
AN:
231342
Hom.:
0
AF XY:
0.000173
AC XY:
22
AN XY:
126802
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000104
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000251
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000915
AC:
133
AN:
1453048
Hom.:
0
Cov.:
36
AF XY:
0.000101
AC XY:
73
AN XY:
722922
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000113
Gnomad4 OTH exome
AF:
0.0000997
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152186
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000261
Hom.:
0
Bravo
AF:
0.0000907
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.000134
AC:
16

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Combined oxidative phosphorylation defect type 23 Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 04, 2014- -
Uncertain significance, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaDec 12, 2019This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,PP5,BP6. -
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxJun 10, 2022Published functional studies demonstrate a damaging effect (reduction of GTPase activity and impaired tRNA modification) (Peng et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as A322P; This variant is associated with the following publications: (PMID: 26832457, 34426522, 33619562, 25434004) -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 22, 2022This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 354 of the GTPBP3 protein (p.Ala354Pro). This variant is present in population databases (rs372174278, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of combined oxidative phosphorylation deficiency (PMID: 25434004). This variant is also known as p.Ala322Pro. ClinVar contains an entry for this variant (Variation ID: 180617). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects GTPBP3 function (PMID: 33619562). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Uncertain
0.050
T
BayesDel_noAF
Uncertain
0.13
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.55
.;D;.;.
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D;D;D
M_CAP
Pathogenic
0.43
D
MetaRNN
Pathogenic
0.93
D;D;D;D
MetaSVM
Benign
-0.36
T
MutationAssessor
Pathogenic
3.0
.;M;.;M
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-4.7
D;D;D;.
REVEL
Uncertain
0.64
Sift
Uncertain
0.0030
D;D;D;.
Sift4G
Uncertain
0.0050
D;D;D;D
Polyphen
1.0
.;D;D;D
Vest4
0.93
MVP
0.73
MPC
1.1
ClinPred
0.88
D
GERP RS
5.0
Varity_R
0.97
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372174278; hg19: chr19-17450398; API